|Articles|July 1, 2020
- Pharmaceutical Executive-07-01-2020
- Volume 40
- Issue 7
Pharmaceutical Executive, July 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 5 years ago
Will COVID-19 Usher in a New Era in Pharma Marketing?over 5 years ago
Is Drug Production Heading Back to Europe From Abroad?over 5 years ago
Central Focus: Targeting Unmet Need in CNSover 5 years ago
Will the Industry Rise to the Occasion?over 5 years ago
How Oncologists are Coping with COVID-19over 5 years ago
Virtual Hiring of the C-Suiteover 5 years ago
Culture and Compliance: Building a Culture of Business Ethicsover 5 years ago
Fauci: Industry Will ‘Walk Away’ From COVID Price Controlsover 5 years ago
A Sustainable Response to COVID-19over 5 years ago
Enterprise Leadership: Is Compliance Ripe for Disruption?Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Sends Amended Acquisition Proposal to Metsera
2
Pharmaceutical Executive Daily: Kimberly-Clark’s $48.7 Billion Acquisition of Kenvue
3
Texas Files to Prevent Kenvue Dividend Payment
4
FDA Approves Kygevvi Becoming the First Treatment for Thymidine Kinase 2 Deficiency
5
